Literature DB >> 7519769

The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine.

J A Latham1, R Johnson, J J Toole.   

Abstract

Combinatorial libraries of nucleic acids are developing into novel sources for lead compounds in drug development. In order to diversify the pool of ss DNA sequences, we have used a modified nucleotide, 5-(1-pentynyl)-2'-deoxyuridine, in place of thymidine in a random nucleic acid library and screened this library against human thrombin. Previously, we described this screening method to identify a novel structural inhibitor (an aptamer) of the coagulation protease thrombin (Bock, L. et. al. (1992) Nature 355 564-566). Using the modified nucleic acid library, we have now isolated a second pool of thrombin inhibitors with strikingly different sequence composition compared to the selection using natural bases. This second class of aptamers is dependent on the presence of the modified nucleotide for protein binding and clotting inhibition. Our method represents a potential strategy to enhance the diversity of libraries for in vitro selection, and thereby increasing the utility of this technique in the identification of molecules with novel biochemical properties.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519769      PMCID: PMC308252          DOI: 10.1093/nar/22.14.2817

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  19 in total

1.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

2.  Enzymatic incorporation of a new base pair into DNA and RNA extends the genetic alphabet.

Authors:  J A Piccirilli; T Krauch; S E Moroney; S A Benner
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962

3.  In vitro selection of RNA molecules that bind specific ligands.

Authors:  A D Ellington; J W Szostak
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

4.  Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection.

Authors:  T K Blackwell; H Weintraub
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

5.  Autogenous translational operator recognized by bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; S Eddy; D Parma; L Gold
Journal:  J Mol Biol       Date:  1990-06-20       Impact factor: 5.469

6.  The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen.

Authors:  M C Naski; J W Fenton; J M Maraganore; S T Olson; J A Shafer
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

7.  A C-nucleotide base pair: methylpseudouridine-directed incorporation of formycin triphosphate into RNA catalyzed by T7 RNA polymerase.

Authors:  J A Piccirilli; S E Moroney; S A Benner
Journal:  Biochemistry       Date:  1991-10-22       Impact factor: 3.162

Review 8.  Deoxyribonucleotide analogs as inhibitors and substrates of DNA polymerases.

Authors:  G E Wright; N C Brown
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

9.  In vitro selection of RNA aptamers specific for cyanocobalamin.

Authors:  J R Lorsch; J W Szostak
Journal:  Biochemistry       Date:  1994-02-01       Impact factor: 3.162

10.  The structure of a complex of recombinant hirudin and human alpha-thrombin.

Authors:  T J Rydel; K G Ravichandran; A Tulinsky; W Bode; R Huber; C Roitsch; J W Fenton
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

View more
  37 in total

1.  Enhancing the catalytic repertoire of nucleic acids: a systematic study of linker length and rigidity.

Authors:  S E Lee; A Sidorov; T Gourlain; N Mignet; S J Thorpe; J A Brazier; M J Dickman; D P Hornby; J A Grasby; D M Williams
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

Review 2.  The Toolbox for Modified Aptamers.

Authors:  Sergey A Lapa; Alexander V Chudinov; Edward N Timofeev
Journal:  Mol Biotechnol       Date:  2016-02       Impact factor: 2.695

3.  DNA-templated polymerization of side-chain-functionalized peptide nucleic acid aldehydes.

Authors:  Ralph E Kleiner; Yevgeny Brudno; Michael E Birnbaum; David R Liu
Journal:  J Am Chem Soc       Date:  2008-03-15       Impact factor: 15.419

4.  Identification and characterization of nucleobase-modified aptamers by click-SELEX.

Authors:  Franziska Pfeiffer; Fabian Tolle; Malte Rosenthal; Gerhard Markus Brändle; Jörg Ewers; Günter Mayer
Journal:  Nat Protoc       Date:  2018-04-26       Impact factor: 13.491

Review 5.  In vitro selection using modified or unnatural nucleotides.

Authors:  Scott M Knudsen; Michael P Robertson; Andrew D Ellington
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2002-02

6.  Blocking the attachment of cancer cells in vivo with DNA aptamers displaying anti-adhesive properties against the carcinoembryonic antigen.

Authors:  Erik W Orava; Aws Abdul-Wahid; Eric H-B Huang; Amirul Islam Mallick; Jean Gariépy
Journal:  Mol Oncol       Date:  2013-04-11       Impact factor: 6.603

Review 7.  All you wanted to know about SELEX.

Authors:  S J Klug; M Famulok
Journal:  Mol Biol Rep       Date:  1994       Impact factor: 2.316

8.  High-affinity and specific recognition of human thyroid stimulating hormone (hTSH) by in vitro-selected 2'-amino-modified RNA.

Authors:  Y Lin; D Nieuwlandt; A Magallanez; B Feistner; S D Jayasena
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

9.  Efficiency and fidelity of T3 DNA ligase in ligase-catalysed oligonucleotide polymerisations.

Authors:  Yi Lei; Joshua Washington; Ryan Hili
Journal:  Org Biomol Chem       Date:  2019-02-13       Impact factor: 3.876

10.  Challenging artificial genetic systems: thymidine analogs with 5-position sulfur functionality.

Authors:  Heike A Held; Steven A Benner
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.